Pharmaceuticals in the United States

Publication ID:

MLI03190035

Publication Date:

March 12, 2019

Pages:

Publisher:

麻豆原创Line

Countries:

USA [1]

USD 350.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Country Overview (Pharma & Healthcare) [4]

Pharma & Healthcare [5]

Description:

Pharmaceuticals in the United States

Summary

Pharmaceuticals in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The US pharmaceuticals market had total revenues of $392.8m in 2018, representing a compound annual growth rate (CAGR) of 4.5% between 2014 and 2018.
- The performance of the market is forecast to decelerate, with an anticipated CAGR of 4.3% for the five-year period 2018-2023, which is expected to drive the market to a value of $484.7m by the end of 2023.
- The market is a largest in the world but the current US President is, to some extent, taking steps to reduce high American drug prices.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in the United States
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the United States
- Leading company profiles reveal details of key pharmaceuticals market players鈥� global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the United States pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the United States pharmaceuticals market by value in 2018?
- What will be the size of the United States pharmaceuticals market in 2023?
- What factors are affecting the strength of competition in the United States pharmaceuticals market?
- How has the market performed over the last five years?
- How large is the United States鈥檚 pharmaceuticals market in relation to its regional counterparts?

Table Of Contents:

Table of Contents
Executive Summary
麻豆原创 value
麻豆原创 value forecast
Geography segmentation
麻豆原创 share
麻豆原创 rivalry
麻豆原创 Overview
麻豆原创 definition
麻豆原创 analysis
麻豆原创 Data
麻豆原创 value
麻豆原创 Segmentation
Geography segmentation
麻豆原创 share
麻豆原创 Outlook
麻豆原创 value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
AstraZeneca PLC
Johnson & Johnson
Merck & Co., Inc.
Pfizer Inc
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related 麻豆原创Line research
Appendix
About 麻豆原创Line

List of Tables
List of Tables
Table 1: United States pharmaceuticals market value: $ billion, 2014-18
Table 2: United States pharmaceuticals market geography segmentation: $ billion, 2018
Table 3: United States pharmaceuticals market share: % share, by value, 2018
Table 4: United States pharmaceuticals market value forecast: $ billion, 2018-23
Table 5: AstraZeneca PLC: key facts
Table 6: AstraZeneca PLC: key financials ($)
Table 7: AstraZeneca PLC: key financial ratios
Table 8: Johnson & Johnson: key facts
Table 9: Johnson & Johnson: key financials ($)
Table 10: Johnson & Johnson: key financial ratios
Table 11: Merck & Co., Inc.: key facts
Table 12: Merck & Co., Inc.: key financials ($)
Table 13: Merck & Co., Inc.: key financial ratios
Table 14: Pfizer Inc: key facts
Table 15: Pfizer Inc: key financials ($)
Table 16: Pfizer Inc: key financial ratios
Table 17: United States size of population (million), 2014-18
Table 18: United States gdp (constant 2005 prices, $ billion), 2014-18
Table 19: United States gdp (current prices, $ billion), 2014-18
Table 20: United States inflation, 2014-18
Table 21: United States consumer price index (absolute), 2014-18
Table 22: United States exchange rate, 2014-18

List of Figures
List of Figures
Figure 1: United States pharmaceuticals market value: $ billion, 2014-18
Figure 2: United States pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 3: United States pharmaceuticals market share: % share, by value, 2018
Figure 4: United States pharmaceuticals market value forecast: $ billion, 2018-23
Figure 5: Forces driving competition in the pharmaceuticals market in the United States, 2018
Figure 6: Drivers of buyer power in the pharmaceuticals market in the United States, 2018
Figure 7: Drivers of supplier power in the pharmaceuticals market in the United States, 2018
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2018
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2018
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2018
Figure 11: AstraZeneca PLC: revenues & profitability
Figure 12: AstraZeneca PLC: assets & liabilities
Figure 13: Johnson & Johnson: revenues & profitability
Figure 14: Johnson & Johnson: assets & liabilities
Figure 15: Merck & Co., Inc.: revenues & profitability
Figure 16: Merck & Co., Inc.: assets & liabilities
Figure 17: Pfizer Inc: revenues & profitability
Figure 18: Pfizer Inc: assets & liabilities

Companies Mentioned:

AstraZeneca PLC
Johnson & Johnson
Merck & Co., Inc.
Pfizer Inc

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.